HER-2/neu as a target for cancer vaccines
HER-2/neu as a target for cancer vaccines
About this item
Full title
HER-2/neu as a target for cancer vaccines
Author / Creator
Publisher
London: Future Medicine Ltd
Journal title
Immunotherapy, 2010-03, Vol.2 (2), p.213-226
Language
English
Formats
Publication information
Publisher
London: Future Medicine Ltd
Subjects
More information
Scope and Contents
Contents
A novel modality toward the treatment of HER-2/neu-positive malignancies, mostly including breast and, more recently prostate carcinomas, has been the use of vaccines targeting HER-2/neu extracellular and intracellular domains. HER-2/neu-specific vaccines have been demonstrated to generate durable T-cell anti-HER-2/neu immunity when tested in Phase...
Alternative Titles
Full title
HER-2/neu as a target for cancer vaccines
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_754897730
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_754897730
Other Identifiers
ISSN
1750-743X
E-ISSN
1750-7448
DOI
10.2217/imt.09.89
How to access this item
Log in as a Library member
